Consumers' interest in immune-boosting products remains at an all time high, and manufacturers are rushing to market with products to fill that need, including many botanical formulas.
The prevalence of virus-treatment claims in the marketplace has made for both heightened enforcement from federal regulators and calls for even more action from an advocacy group regarding products sold on Amazon.
The National Adverting Division has joined in the battle against coronavirus disease claims by advising a company marketing a superfoods blend to take down a video that NAD says crosses the line.
Hemp cannabidiol (CBD) supplier and manufacturer CV Sciences just announced fresh research that demonstrates the safety and health benefits of its PlusCBD products.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
The National Advertising Division has ruled that GSK must stop calling some of its Benefiber prebiotic supplements ‘100% natural.’ It’s a ruling that could be viewed as troublesome for other prebiotic ingredients.
The Federal Trade Commission has sent out another round of warning letters to 50 more marketers nationwide, most of which are labeled as dietary supplements or Chinese herbs.
Plant cell culture is an inviting technology to produce bioactives from certain botanicals. The approach is a difficult one to master, however, which is a primary reason why it is still somewhat rare in the market.
New claims creeping into the hemp/CBD space are indicative of the some of the unsolved regulatory issues that continue to distort the market. These include claims of ‘zero THC’ and ‘no CBD isolate.’
The ongoing CBD regulatory logjam has stunted the development of responsible, informative health claims for these products. I’ve speculated in these pages before that this will lead consumers to make it up as they go along. Two new studies seem to confirm...
The Federal Trade Commission just announced it is issuing refund checks totaling over $8.5 million to consumers defrauded by misleading claims on weight loss products an erectile dysfunction product in a case dating back to 2004.
The Food and Drug Administration (FDA) may have suspended all routine plant inspections, but dietary supplement producers are still expected to remain in compliance. In the meantime, the Federal Trade Commission has sent another 37 warning letters over...
